Elevance Health, Inc. — Form 10-Q
Filed July 15, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
CEO Gail K. Boudreaux and CFO Mark B. Kaye certified on July 15, 2026 that the Q2 2026 Form 10-Q fairly presents Elevance Health's financial condition and results of operations, with effective disclosure controls and internal controls over financial reporting. No material weaknesses, significant deficiencies, or fraud were disclosed.
Why this rating
Routine Sarbanes-Oxley certification exhibits; no operational, financial, or control changes disclosed; boilerplate periodic filing requirement.
See more from July 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.